1. Market Research
  2. > Biotechnology Market Trends
  3. > Global Genetic Engineering Industry

Global Genetic Engineering Industry

  • January 2012
  • -
  • Global Industry Analysts

Summary

Table of Contents

The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers an aerial view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry’s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. Market discussions in the report are punctuated with fact-rich market data tables. Regional markets elaborated upon include United States, Canada, India, China, and South Africa among others. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 153 companies active in the market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016-2020 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

2016-2020 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

  • $ 9 850
  • Industry report
  • March 2016
  • by Venture Planning Group

This report provides the following data: Geographic Coverage:-          France-          Germany-          Italy-          Japan-          Spain-          ...

Head and Neck Squamous Cell Carcinoma: KOL Insight

Head and Neck Squamous Cell Carcinoma: KOL Insight

  • $ 8 085
  • Industry report
  • March 2016
  • by Firstword Pharma

n/a

Rheumatoid Arthritis: KOL Insight

Rheumatoid Arthritis: KOL Insight

  • $ 8 085
  • Industry report
  • March 2016
  • by Firstword Pharma

Leading brands under threat as biosimilars and new pipeline drugs hit the market Key opinion leaders (KOLs) say Rheumatoid Arthritis (RA) treatment is in for a shakeup thanks to anti-TNF biosimilars, new ...


ref:plp2012

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.